CINECA IRIS Institutional Research Information System

GUERRINI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.527
EU - Europa 2.377
AS - Asia 2.239
SA - Sud America 377
AF - Africa 127
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 5
Totale 9.670
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.380
IT - Italia 808
CN - Cina 690
SG - Singapore 661
SE - Svezia 489
HK - Hong Kong 385
BR - Brasile 331
GB - Regno Unito 277
DE - Germania 268
BG - Bulgaria 174
VN - Vietnam 173
CA - Canada 113
TR - Turchia 109
RU - Federazione Russa 80
FI - Finlandia 76
CI - Costa d'Avorio 54
FR - Francia 47
IN - India 45
UA - Ucraina 35
BE - Belgio 33
JP - Giappone 33
SN - Senegal 28
KR - Corea 26
PH - Filippine 23
MX - Messico 20
AU - Australia 18
ES - Italia 15
BD - Bangladesh 14
NL - Olanda 14
AR - Argentina 13
PL - Polonia 13
CH - Svizzera 12
PK - Pakistan 11
UZ - Uzbekistan 11
SA - Arabia Saudita 10
EC - Ecuador 9
NG - Nigeria 9
ZA - Sudafrica 9
KE - Kenya 7
MA - Marocco 7
TN - Tunisia 7
CZ - Repubblica Ceca 6
IQ - Iraq 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
AT - Austria 5
ID - Indonesia 5
LT - Lituania 5
MY - Malesia 5
CO - Colombia 4
EG - Egitto 4
GR - Grecia 4
IR - Iran 4
JO - Giordania 4
PY - Paraguay 4
RO - Romania 4
UY - Uruguay 4
CL - Cile 3
DK - Danimarca 3
EU - Europa 3
IE - Irlanda 3
KZ - Kazakistan 3
BM - Bermuda 2
BS - Bahamas 2
BT - Bhutan 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
PS - Palestinian Territory 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
EE - Estonia 1
ET - Etiopia 1
IL - Israele 1
KW - Kuwait 1
MD - Moldavia 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
SI - Slovenia 1
SR - Suriname 1
SY - Repubblica araba siriana 1
Totale 9.670
Salva come PNG Salva come JPEG
Città #
Ashburn 487
Serra 388
Hong Kong 383
Woodbridge 365
Fairfield 359
Singapore 338
Santa Clara 324
Ann Arbor 271
Houston 269
Chandler 261
Dallas 232
Beijing 198
Seattle 193
Sofia 170
Shanghai 151
Wilmington 146
Cambridge 125
New York 120
Boardman 111
Milan 97
Princeton 86
Los Angeles 82
London 80
Ottawa 78
Munich 67
Florence 66
Medford 60
Izmir 59
Lawrence 59
Abidjan 54
Jacksonville 42
Des Moines 41
Dearborn 35
Nanjing 35
Istanbul 30
Dakar 28
San Diego 28
Dong Ket 27
Ho Chi Minh City 26
Brussels 23
Lancaster 23
Pisa 23
Buffalo 22
São Paulo 22
Bremen 20
Frankfurt am Main 20
Redwood City 20
Rome 20
Nanchang 19
Redondo Beach 19
Tokyo 19
Hanoi 18
Hefei 18
Rio de Janeiro 18
Turku 16
Changsha 14
Council Bluffs 14
Helsinki 14
Shenyang 14
Alessandria 12
San Jose 12
Düsseldorf 11
Fuzhou 11
Manila 11
Toronto 11
Columbus 10
Nuremberg 10
Phoenix 10
Tashkent 10
The Dalles 10
Duncan 9
Falkenstein 9
Lagos 9
Porto Alegre 9
Warsaw 9
Bern 8
Brooklyn 8
Hebei 8
Jüchen 8
Melbourne 8
Montreal 8
Boston 7
Boulder 7
Cascina 7
Chengdu 7
Denver 7
East Lansing 7
Hangzhou 7
Jiaxing 7
Kunming 7
Nairobi 7
Norwalk 7
Seoul 7
Amsterdam 6
Ankara 6
Campinas 6
Chicago 6
Falls Church 6
Guangzhou 6
Nürnberg 6
Totale 6.684
Salva come PNG Salva come JPEG
Nome #
The perception of stress in cat owners 303
Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen. Leuk Lymphoma 230
The Droplet Digital PCR: A New Valid Molecular Approach for the Assessment of B-RAF V600E Mutation in Hairy Cell Leukemia 220
Quantitative molecular monitoring of BCR-ABL and MDR1 transcripts in patients with chronic myeloid leukemia during Imatinib treatment 206
Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia 204
The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia 197
Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen 194
Reduced circulating B-lymphocytes and altered B-cell compartments in patients suffering from chronic myeloid leukaemia undergoing therapy with Imatinib 194
Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study. 193
Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines 187
Combined unfavourable polymorphisms ofhOCT1 and ABCG2 are responsible for delayed complete cytogenetic response during imatinib treatment. 181
Polycomb genes are associated with response to imatinib in chronic myeloid leukemia 180
Transmembrane Transporters hOCT1 and SLCO1B3 Polymorphisms Could Have a Role in Patients Affected By Chronic Myeloid Leukemia Treated with Nilotinib 176
The combination of rituximab and bendamustine as first-line treatment is highly effective in the eradicating minimal residual disease in follicular lymphoma: An Italian retrospective study 174
TCR REARRANGEMENTS ARE NOT ENOUGH FOR DISTINGUISHING THE CHURG-STRAUSS SYNDROME FROM THE HYPEREOSINOPHILIC SYNDROME 173
A PRACTICAL APPROACH TO THERAPEUTIC DRUG MONITORING OF IMATINIB IN PATIENTS AFFECTED BY CHRONIC MYELOID ELEUKEMIA. THE TIKLET PROTOCOL. 170
Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: The FIL FOLL05 trial 170
MDS: An Integrated Workup for a Correct Diagnosis 168
The WNT pathway is relevant for the BCR-ABL1-independent resistance in chronic myeloid leukemia 168
Significant co-expression of WT1 and MDR1 genes in acute myeloid leukemia patients at diagnosis 166
Droplet digital PCR represents a new sensitive method for detecting B-RAFV600E mutation at diagnosis and during the follow-up of patients affected by hairy cell leukemia 163
High-dose zinc oral supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naïve lymphocytes and prevents TTV reactivation 163
Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders. 163
Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines 160
TCR GAMMA CLONALITY ASSESSED BY NGS DOES NOT HELP TO DISTINGUISH EGPA FROM HES 160
PLATELET-DERIVED GROWTH FACTOR BETA RECEPTOR (PDGFRB) GENE IS REARRANGED IN A SIGNIFICANT PERCENTAGE OF MYELODYSPLASTIC SYNDROMES WITH NORMAL KARYOTYPE 160
Increased values of the circulating PDGFβ sustains the "withdrawal syndrome" after tyrosine kinase inhibitor discontinuation in patients affected by chronic myeloid leukemia 157
Myelodysplastic syndromes: advantages of a combined cytogenetic and molecular diagnostic workup 157
Molecular detection of GNNK- and GNNK+ c-kit isoforms: a new tool for risk stratification in adult acute myeloid leukaemia 156
Comparison of Real-Time PCR and Droplet Digital PCR for the Determination of JAK2V617F Mutation in Ph'-Negative Myeloproliferative Neoplasms 156
LOW RPS14 EXPRESSION IS FREQUENTLY FOUND IN NON-5Q-MYELODYSPLASTIC SYNDROMES 154
Evaluation of BCRP and MDR-1 co-expression by quantitative molecular assessment in AML patients 149
A Novel Digital PCR Assay for MYD88 L265P Mutation Detection in Waldenstrom Macroglobulinemia: Minimal Residual Disease Monitoring and Characterization on Circulating Free DNA 146
The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patients 145
Combined FAMD and ANOVA investigation leads to significant association between the hOCT1/ABCB1 diplotype and both efficacy and tolerability in patients affected by chronic myeloid leukemia 144
Altered Expression of Jak-Stat Pathway as Possible Predictive Marker in Patients Affected by Chronic Myeloid Leukemia Receiving Tyrosin Kinase Inhibitors (TKIS) 143
Quantitative molecular evaluation in autotransplant programs for follicular lymphoma: efficacy of in vivo purging by Rituximab 142
ZINC ORAL SUPPLEMENTATION INDUCES A SIGNIFICANT RISE OF TRECS AND T CD4+ NAΪVE AND PREVENTS THE INCREASE OF TTV VIRAL LOAD AFTER STEM CELL TRANSPLANTATION: THE ZENITH STUDY 140
The Minimal Residual Disease in Non-Hodgkin's Lymphomas: From the Laboratory to the Clinical Practice 140
WT1 expression levels at diagnosis could predict long-term time-to-progression in adult patients affected by acute myeloid leukaemia and myelodysplastic syndromes 138
The Polycomb BMI1 Protein Is Co-expressed With CD26+ in Leukemic Stem Cells of Chronic Myeloid Leukemia 133
Sorafenib Induced Complete Cytogenetic and Molecular Response in a Chronic Eosinophilic Leukemia Case with t(12;13) Translocation 130
PRDI-BF1 and PRDI-BF1P isoform expressions correlate with disease status in multiple myeloma patients 129
Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2 129
Vorinostat interferes with Wnt and NF-kappaB pathways in the M-07e cell line 128
Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantation 127
TCR GAMMA CLONALITY ASSESSED BY NGS DOES NOT HELP TO DISTINGUISH EOSINOPHILOIA IN EGPA FROM HES 126
Quantitative molecular evaluation of minimal residual disease in patients with chronic lymphocytic leukemia: efficacy of in vivo purging by alemtuzumab (Campath-1H). 125
The role of molecular monitoring in autotransplantation for non-Hodgkin's lymphoma 124
Platelet-derived growth factor beta receptor (PDGFRB) gene is rearranged in a significant percentage of myelodysplastic syndromes with normal karyotype 122
Conventional Cytogenetics, ACGH, and PCR as Integrated Workup for a Correct Diagnosis of MDS 122
Peripheral blood stem cell contamination evaluated by a highly sensitive molecular method fails to predict outcome of autotransplanted multiple myeloma patients 120
R-IPSS, RPS14 AND WT1 LEVELS ARE THE BEST PROGNOSTIC FACTORS FOR PATIENTS AFFECTED BY MYELODYSPLASTIC SYNDROMES DURING AZACITIDINE TREATMENT. 119
The clinical relevance of the expression of several multidrug-resistant-related genes in patients with primary acute myeloid leukemia 118
ITF2357 interferes with apoptosis and inflammatory pathways in the HL-60 model: a gene expression study. 115
TYROSINE KINASE INHIBITORS SIGNIFICANTLY CHANGE THE EXPRESSION OF POLYCOMB GENES IN CHRONIC MYELOID LEUKEMIA 115
Myelodysplastic Syndromes: A Multidisciplinary Integrated Diagnostic Work-up for Patients' Risk Stratification 112
FLT3 mutations do not influence MDR-1 gene expression in acute myeloid leukemia 108
quantitative molecular detection of IgH rearrangement in multiple myeloma: comparison of two innovative techniques 104
Highly sensitive MYD88L265P mutation detection by droplet digital polymerase chain reaction in Waldenström macroglobulinemia 103
THE C.480C>G POLYMORPHISM OF HOCT1 TRANSPORTER INFLUENCES IMATINIB CLEARANCE IN PATIENTS AFFECTED BY CHRONIC MYELOID LEUKEMIA 102
Digital droplet PCR is a specific and sensitive tool for detecting IDH2 mutations in acute myeloid leukemia patients 102
Real-Time PCR and Droplet Digital PCR: two techniques for detection of the JAK2(V617F) mutation in Philadelphia-negative chronic myeloproliferative neoplasms 100
molecular evaluation of minimal residual disease in multiple myeloma 86
A new digital droplet PCR method for looking at epigenetics in diffuse large B‐cell lymphomas: The role of BMI1, EZH2, and USP22 genes 77
Digital Droplet PCR in Hematologic Malignancies: A New Useful Molecular Tool 66
Totale 9.832
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.034
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.034
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021422 0 0 0 0 0 31 42 44 64 45 54 142
2021/2022859 30 42 13 64 144 117 30 32 70 29 70 218
2022/20231.062 159 210 68 72 86 116 8 85 168 6 79 5
2023/2024691 59 54 97 40 77 120 37 19 9 44 22 113
2024/20252.284 11 75 15 131 258 243 198 134 208 279 217 515
2025/20261.412 170 255 290 224 265 208 0 0 0 0 0 0
Totale 9.832